Investing Profile

Bali Muralidhar

InvestorVC
Managing Partner at Abingworth
abingworth.com/team/bali-mura...London
Photo of Bali Muralidhar, Managing Partner at Abingworth
Your Intro Paths to Bali Muralidhar

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Bali Muralidhar on

cb
Current Investing Position
Abingworth Managing Partner
Investment Range
$15.0M - $30.0M
Sweet Spot
$22.5M
Investments On Record
12
Current Fund Size
$465M

Bali Muralidhar is on these Sector & Stage Rankings

Bali Muralidhar's Investments On Record (11)

CompanyStageDateRound SizeTotal Raised
Glycomine
Series CApr 2025$120M
Series BJun 2021$35M
$150M
Co-investors: Niall O’Donnell (RiverVest), Dominic Schmidt (Advent Life Sciences), Jim Trenkle (Sanofi Ventures)
AdvanCell
Series CFeb 2025$110M
$110M
Co-investors: Jamil Beg (5am Ventures), Christopher Gagliardi (Sanofi Ventures)
Ascend Gene & Cell Therapies
Series AMay 2023$66M
$66M
Anjarium Biosciences
Series ASep 2021$60M
$60M
CymaBay Therapeutics
Post Ipo DebtAug 2021$100M
$190M
Co-investors: Andrew Schwab (5am Ventures), Tony Evnin (Venrock)
Wugen
Series BJul 2021$170M
$170M
Co-investors: John McKearn (RiverVest)
Reneo Pharmaceuticals
Series BDec 2020$95M
$150M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Niall O’Donnell (RiverVest)
NuCana BioMed
Post Ipo EquityOct 2020$80M
$140M
Co-investors: James Healy (Sofinnova Investments)

Founders who looked at Bali Muralidhar's profile also looked at these Scouts & Angels

Photo of Gokul Rajaram, Angel

Photo of Josh Elman, Angel

Photo of Ryan Walsh, Angel

Photo of Kevin Lee, Angel